Liver health may change how this drug works
NCT ID NCT04676425
First seen May 11, 2026 · Last updated May 11, 2026
Summary
This study looked at how the drug MK-8189 (elpipodect) behaves in people with mild or moderate liver problems compared to healthy people. Researchers measured drug levels in the blood and checked for side effects. The goal was to understand if liver impairment changes how the body processes the drug, which helps guide safe dosing. The study involved 14 participants and is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Pharmacology of Miami ( Site 0001)
Miami, Florida, 33014, United States
-
ProSciento Inc. ( Site 0002)
Chula Vista, California, 91911, United States
Conditions
Explore the condition pages connected to this study.